Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
search
Subscribe
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
Subscribe
FREE
Hepatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Hepatitis B Vaccine Response After Allogeneic HSCT
November 2025
Interestingly, the timing of vaccination, often initiated within 12 months post-transplant, did not significantly influence antibody development.
Read more
3 Nov 2025
Hepatitis B Vaccine Response After Allogeneic HSCT
Interestingly, the timing of vaccination, often initiated within 12 months post-transplant, did not significantly influence antibody development.
1 Nov 2025
Benefits of Virtual Reality CT-Guided Liver Biopsy Training
While the control group demonstrated no notable change, the intervention group showed a clear improvement in knowledge immediately after completing the VR module.
30 Oct 2025
TACE-Induced Liver Injury Linked to Gut Microbiota
By targeting the gut-liver axis, administration of L. reuteri or ILA could become a novel therapeutic approach to prevent TACE-LI.
28 Oct 2025
PEth Levels in SLD Predict Liver Disease Risk
Discover a study showing how PEth levels identify alcohol use and predict adverse outcomes in MASLD, MetALD, and ALD patients.
26 Oct 2025
High Cure Rates in HCV Treatment Achieved
The DRIVE-C study in Haiphong, Vietnam, evaluated a community-based strategy to screen PWID for HCV and provide access to direct-acting antivirals.
24 Oct 2025
Facilitated Telemedicine Boosts Healthcare Access
A randomised controlled trial examined the effectiveness of facilitated telemedicine for hepatitis C virus treatments.
22 Oct 2025
Curcumin in MASLD and Type 2 Diabetes Treatment
A 12-month randomised controlled trial investigated curcumin supplementation in Type 2 diabetes treatment, specifically its effects on liver steatosis.
18 Oct 2025
NOD1 Signalling in Acute Liver Failure
The study examined transcriptome data from patients with HBV-induced acute liver failure and healthy controls, identifying key genes and pathways linked to disease progression.
Loading posts...
1
2
3
…
37
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View